Chair
The Ohio State University
Columbus, Ohio, United States
Russell R. Lonser received his M.D. from Loma Linda University. Upon completion of his residency the University of Utah (2001), he joined the staff of the Surgical Neurology Branch at the National Institutes of Health (NIH). He was Chief of the Surgical Neurology Branch at NIH before becoming Professor and Chair of the Department of Neurological Surgery at Ohio State University in 2012. He holds the Dardinger Family Chair in Neurosurgical Oncology.
Dr. Lonser’s research interests include development of drug delivery paradigms for the central nervous system pathology. He is an author on over 350 scientific and clinical publications. He received the Tumor Young Investigator Award from the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors (2001) and Mahaley Clinical Research Award from the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors (2013). He was the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors Bittner Lecturer (2017) and the American Academy of Neurological Surgery Edward H. Oldfield Lecturer (2018).
His contributions to organized neurosurgery include membership on the Executive Committee of the Congress of Neurological Surgeons. He was the Treasurer and President of the Congress of Neurological Surgeons. He is the Secretary of the American Board of Neurological Surgeons. He was the head of the Research Subcommittee in Head, Neck and Spine Injury Committee for the National Football League for 10 years. He has been actively involved in the mentoring and training of over 40 neurosurgical fellows. He has served on the Editorial Boards for NEUROSURGERY, World Neurosurgery and Journal of Neurosurgery. He is Academic Editor for PLoS One and Science Reports. He is Consulting Editor for Neurosurgery Clinics of North America and Associate Editor for Neurosurgery. He has edited 4 drug delivery and neurosurgical textbooks.
(PS2) Washington Committee Update
Sunday, April 23, 2023
9:46am – 9:49am PST
Disclosure(s): Biogen: Advisor (Ongoing); Eikonklastes, Inc.: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Uniqure: Advisor (Ongoing); Zheimer Therapeutics, Inc.: Stock Shareholder (excluding mutual funds) (Ongoing)
(PS2) Introduction: Hunt Wilson Lecture
Sunday, April 23, 2023
9:50am – 9:52am PST
Disclosure(s): Biogen: Advisor (Ongoing); Eikonklastes, Inc.: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Uniqure: Advisor (Ongoing); Zheimer Therapeutics, Inc.: Stock Shareholder (excluding mutual funds) (Ongoing)